Transcript - Chapter 10 of 10 - Conclusion

1:39:07 - 1:44:06 - Interactive sourced transcript
Dr. STANISLAW BURZYNSKI - on camera interview: The entire approach is totally wrong. It’s based on the microscopic diagnosis of cancer which is about one hundred and sixty years old. Without really looking at what is causing cancer, without looking for the genetic signature of the cancer—the technology in this area is developing, it’s available today if somebody would like to use it he can have at least some idea of what is ”the best to use for this patient”. But the doctors are uniformly resistant against it, they don’t want to hear about it, they just use the combination of medicines in which they have learned by heart, and they know that that’s what they should use for everybody. Terrible waste, waste of resources, a terrible waste of human lives because in the meantime these patients obviously will not respond and they could respond if they would be given good medicine. Terrible waste of resources from the large insurance companies, as they will obviously pay for very expensive regimens which are going to fail, but at the same time when you try to select what is the best medicine for a patient based on their genetic signature they may not pay you, because they say “no, this medicine is not yet FDA approved, and it shouldn’t be used.” It’s a totalitarian approach: everybody's the same, everybody should receive the same medical regimen, and don’t you dare look at somebody as an individual—treat everybody the same way. It’s good for the pharmaceutical companies because they will make billions of dollars, good for doctors who don’t want to learn much because they need to learn medicine by heart, and they can use the same thing all over again for a number of years. But of course bad news for patients who are going to have adverse reactions and very few of them will have real good results. That’s a problem. Dr. JULIAN WHITAKER - on camera interview: True progress in medicine has always, without exception, been violently resisted by medical authorities who cling to the beliefs of their time. In 1840, Ignaz Semmelweis, an Austrian obstetrician noted that over 20%, that’s one out of five, women giving birth in the hospital died four to six days later of puerperal fever. These women were then autopsied in the basement of the hospital. And the doctors who performed these autopsies wore no gloves, can you imagine that? Believe it or not, they then would leave

the autopsy room and go straight to the delivery room to assist other births without even washing their hands. Then Dr. Semmelweis’ good friend and fellow physician accidentally cut his finger while he was doing an autopsy. In six days, this doctor died with the same signs and symptoms of puerperal fever. All of the sudden Semmelweis knew, he realized that the doctors were transferring the disease from the autopsy room to the delivery room, and he urged his colleagues to simply wash their hands. For this unforgivable sacrilege, he was drummed out of the medical profession and he died in an insane asylum. [SOURCE: Ignaz Semmelweis Wiki] Now today we have the same kind of arrogant commitment to belief, but with cancer treatment we have a trillion-dollar business built on those beliefs. So if you think Semmelweis had a problem, just imagine the problem Dr. Burzynski faces. There was no money involved in “hand washing” vs. “non-hand washing”. Dr. STANISLAW BURZYNSKI - on camera interview: The smear campaign against us continues, from good doctors, from the American Medical Association, from the American Cancer Society. Despite of the fact that it should have stopped a long time ago. The fact that we are permitted to enter Phase 3 trials means that the treatment already shows safety and efficacy in Phase 2 trials. This means that at this moment we should receive overwhelming support, instead of being harassed as we are so far. ON SCREEN TITLE CARDS: In 2009, Phase II FDA-supervised clinical trials of Antineoplastons successfully came to a close. Phase III trials are the third and final phase before reaching FDA approval. These trials could being worldwide in 2010, barring the ability to raise the money to fund them. The FDA has officially mandated that some patients participating in these Phase III trials also be subjected to radiation treatment while simultaneously receiving Antineoplaston treatment—claiming it would be “unethical” not to do so. It is simply a matter of time before Antineoplastons and other forms of gene-targeted therapy will begin to replace chemotherapy and radiation for the treatment of most cancers. [SOURCE: B Healy US New World Report 2008] This film is dedicated to everyone who has been affected by cancer. All original documents and sources used in this film, plus much more additional information will be openly available for you to obtain and research for yourself at: [SOURCE] ON SCREEN TITLE CARDS (continued): Written, directed, and produced by Eric Merola


ENDING CREDITS: Special thanks to Stanislaw Burzynski, MD, PhD for his generous cooperation in the making of this film. Special thanks to Julian Whitaker, MD for his courageous support of Dr. Burzynski and his invaluable contribution to this film. Special thanks to Richard A. Jaffe, Esq. for his commitment in helping to maintain Dr. Burzynski’s freedom, and Carolyn Powers for her tireless hours spent in Dr. Burzynski’s extensive records rooms locating many of the documents presented in this film.


Sign up to vote on this title
UsefulNot useful